Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8527)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2019 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang WX, Zhang Y, Qin G, Li KM, Wei W, Li SY, Yao SK. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2019; 25(43): 6416-6429 [PMID: 31798278 DOI: 10.3748/wjg.v25.i43.6416] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i43/6416.htm |
| Number | Citing Articles |
| 1 |
Boli Cheng, Qunying Sun, Xinghui Li, Meng Xiao, Xiaoqin Wei, Si Wang. Vitamin A deficiency from maternal gestation may contribute to autistic-like behaviors and gastrointestinal dysfunction in rats through the disrupted purine and tryptophan metabolism. Behavioural Brain Research 2023; 452: 114520 doi: 10.1016/j.bbr.2023.114520
|
| 2 |
Bani Ahluwalia, Cristina Iribarren, Maria K. Magnusson, Johanna Sundin, Egbert Clevers, Otto Savolainen, Alastair B. Ross, Hans Törnblom, Magnus Simrén, Lena Öhman. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome. Cells 2021; 10(6): 1459 doi: 10.3390/cells10061459
|
| 3 |
Fumie Hamano, Suzumi M. Tokuoka, Megumi Ishibashi, Yasuto Yokoi, Dieter M. Tourlousse, Yoshihiro Kita, Yuji Sekiguchi, Hiroyuki Yasui, Takao Shimizu, Yoshiya Oda. Multi-Omics Analysis to Generate Hypotheses for Mild Health Problems in Monkeys. Metabolites 2021; 11(10): 701 doi: 10.3390/metabo11100701
|
| 4 |
Cristina Iribarren, Sofia Nordlander, Johanna Sundin, Stefan Isaksson, Otto Savolainen, Hans Törnblom, Maria K. Magnusson, Magnus Simrén, Lena Öhman. Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids. Neurogastroenterology & Motility 2022; 34(10) doi: 10.1111/nmo.14390
|
| 5 |
Maroulla D. Nikolaki, Arezina N. Kasti, Konstantinos Katsas, Konstantinos Petsis, Sophia Lambrinou, Vasiliki Patsalidou, Sophia Stamatopoulou, Katerina Karlatira, John Kapolos, Konstantinos Papadimitriou, Konstantinos Triantafyllou. The Low-FODMAP Diet, IBS, and BCFAs: Exploring the Positive, Negative, and Less Desirable Aspects—A Literature Review. Microorganisms 2023; 11(10): 2387 doi: 10.3390/microorganisms11102387
|
| 6 |
Xuan Ju, Zhenliang Jiang, Jiayin Ma, Dong Yang. Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis. Nutrients 2024; 16(11): 1727 doi: 10.3390/nu16111727
|
| 7 |
Tong Liu, Xiang Gu, Li-Xiang Li, Ming Li, Bing Li, Xiao Cui, Xiu-li Zuo. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients. BMC Microbiology 2020; 20(1) doi: 10.1186/s12866-020-01841-4
|
| 8 |
Peter Paine. Review article: current and future treatment approaches for pain in IBS. Alimentary Pharmacology & Therapeutics 2021; 54(S1) doi: 10.1111/apt.16550
|
| 9 |
Caroline J Tuck, Amal Abu Omar, Giada De Palma, Samira Osman, Nestor N Jiménez-Vargas, Yang Yu, Sean MP Bennet, Cintya Lopez-Lopez, Josue O Jaramillo-Polanco, Corey C Baker, Aidan SW Bennett, Mabel Guzman-Rodriguez, Quentin Tsang, Taylor Alward, Sebastien Rolland, Celine Morissette, Elena F Verdu, Premysl Bercik, Stephen J Vanner, Alan E Lomax, David E Reed. Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain. Gut 2023; 72(9): 1678 doi: 10.1136/gutjnl-2022-327260
|
| 10 |
Clara Depommier, Amandine Everard, Céline Druart, Dominique Maiter, Jean-Paul Thissen, Audrey Loumaye, Michel P. Hermans, Nathalie M. Delzenne, Willem M. de Vos, Patrice D. Cani. Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1994270
|
| 11 |
Brent J. Gawey, Ruben A. Mars, Purna C. Kashyap. The role of the gut microbiome in disorders of gut–brain interaction. The FEBS Journal 2024; doi: 10.1111/febs.17200
|
| 12 |
Qi-Yun Xiao, Xiu-Cai Fang, Xiao-Qing Li, Gui-Jun Fei. Ethnic differences in genetic polymorphism associated with irritable bowel syndrome. World Journal of Gastroenterology 2020; 26(17): 2049-2063 doi: 10.3748/wjg.v26.i17.2049
|
| 13 |
Giorgio Gargari, Giacomo Mantegazza, Valentina Taverniti, Claudio Gardana, Alice Valenza, Federico Rossignoli, Maria Raffaella Barbaro, Giovanni Marasco, Cesare Cremon, Giovanni Barbara, Simone Guglielmetti. Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2274128
|
| 14 |
Kirsten Berding, Klara Vlckova, Wolfgang Marx, Harriet Schellekens, Catherine Stanton, Gerard Clarke, Felice Jacka, Timothy G Dinan, John F Cryan. Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health. Advances in Nutrition 2021; 12(4): 1239 doi: 10.1093/advances/nmaa181
|
| 15 |
Hans Stenlund, Clara Nilholm, Elin Chorell, Bodil Roth, Mauro D’Amato, Bodil Ohlsson. Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet. Metabolites 2021; 11(7): 440 doi: 10.3390/metabo11070440
|
| 16 |
M. M. Fedorin, M. A. Livzan, O. V. Gaus, E. V. Pashkova. Potential role of short-chain fatty acids in irritable bowel syndrome in overweight and obese individuals. Meditsinskiy sovet = Medical Council 2024; (8): 20 doi: 10.21518/ms2024-168
|
| 17 |
Cristina Iribarren, Lujain Maasfeh, Lena Öhman, Magnus Simrén. Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microbiome 2022; 3 doi: 10.1017/gmb.2022.6
|
| 18 |
Maria Kulecka, Natalia Zeber-Lubecka, Aneta Bałabas, Paweł Czarnowski, Katarzyna Bagińska, Maria Głowienka, Anna Kluska, Magdalena Piątkowska, Michalina Dąbrowska, Edyta Waker, Michał Mikula, Jerzy Ostrowski. Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1190910
|
| 19 |
Lei-Min Yu, Min-Na Weng, Hui-Jun Chen, Wei Ye, Yi-Hong Fan. Study of efficacy and mechanism of low FODMAPs diet on diarrhea-type irritable bowel syndrome based on a gut microbiota-dependent metabolite. World Chinese Journal of Digestology 2021; 29(24): 1421 doi: 10.11569/wcjd.v29.i24.1421
|
| 20 |
Sabrina Berens, Yuanjun Dong, Nikola Fritz, Jutta Walstab, Mauro D'Amato, Tenghao Zheng, Verena Wahl, Felix Boekstegers, Justo Lorenzo Bermejo, Cristina Martinez, Stefanie Schmitteckert, Egbert Clevers, Felicitas Engel, Annika Gauss, Wolfgang Herzog, Robin Spiller, Miriam Goebel-Stengel, Hubert Mönnikes, Viola Andresen, Frieling Thomas, Jutta Keller, Christian Pehl, Christoph Stein-Thöringer, Gerard Clarke, Timothy G Dinan, Eamonn M Quigley, Gregory Sayuk, Magnus Simrén, Jonas Tesarz, Gudrun Rappold, Lukas van Oudenhove, Rainer Schaefert, Beate Niesler. Serotonin type 3 receptor subunit gene polymorphisms associated with psychosomatic symptoms in irritable bowel syndrome: A multicenter retrospective study. World Journal of Gastroenterology 2022; 28(21): 2334-2349 doi: 10.3748/wjg.v28.i21.2334
|
| 21 |
Zulmary Manjarres, Margarita Calvo, Rodrigo Pacheco, Habibeh Khoshbouei. Regulation of Pain Perception by Microbiota in Parkinson Disease. Pharmacological Reviews 2024; 76(1): 7 doi: 10.1124/pharmrev.122.000674
|